Malignant hyperthermia triggered by isoflurane and suxamethonium in a patient who underwent apparently uneventful halothane anesthesia previously: a case report

Kudoh, Akira; Kikuchi, Atuhiro; Wakayama, Shigeharu; Ishihara, Hironori; Matsuki, Akitomo
July 1999
Journal of Anesthesia;1999, Vol. 13 Issue 3, p181
Academic Journal
Presents information on a case of fulminant malignant hyperthermia (MH) caused by isoflurane and suxamethonium but not by halothane anesthesia. Details on MH; Discussion on isoflurane and halothane as triggering drugs for MH; Development of MH in patients with musculoskeletal defects.


Related Articles

  • Halothane/isoflurane/suxamethonium chloride.  // Reactions Weekly;6/20/2009, Issue 1257, p22 

    The article describes ten cases of patients who acquired suspected postoperative malignant hyperthermia. The patients were operated through surgical procedures with anaesthesia for 35 to 660 minutes. The triggering agents reported were isoflurane in four cases, isoflurane and suxamethonium...

  • Isoflurane.  // Reactions Weekly;5/8/2010, Issue 1300, p30 

    The article describes the case of a 69-year-old man who developed malignant hyperthermia after receiving isoflurane during a routine coronary artery bypass for severe coronary artery disease.

  • Isoflurane.  // Reactions Weekly;Sep2015, Vol. 1569 Issue 1, p137 

    The article presents a case study of a 13-year-old boy who developed malignant hyperpyrexia after isoflurane treatment.

  • Malignant Hyperthermia.  // Encyclopedic Reference of Molecular Pharmacology;2004, p574 

    An encyclopedia entry for the term "malignant hyperthermia" is presented. Characteristic signs and symptoms shown by humans with the genetic trait malignant hyperthermia include tachycardiac arrhythmia, cyanosis, acidosis, muscle contracture and high fever when exposed to inhalation of general...

  • Ring fibers visualized by electron microscopy in a Japanese patient with malignant hyperthermia. Yoshimasa Kitagawa; Masaru Kuriyama; Kazuo Sano; Kenji Hashimoto; Sato, Jun // Odontology;Jan2011, Vol. 99 Issue 1, p101 

    This report describes an episode of malignant hyperthermia (MH) in a 53-year-old Japanese man during general anesthesia that was triggered by isoflurane and succinylcholine. His past history and family history were unremarkable. From our analysis of ten exons, he had no recognizable mutation in...

  • Isoflurane.  // Reactions Weekly;1/11/2014, Issue 1483, p57 

    The article presents a case report on the adverse reaction of isoflurane to a 22-year-old man who developed acute malignant hyperthermia (MH) after receiving the treatment.

  • Malignant Hyperthermia during Third Exposure to Volatile Anesthetic Agents. January-Butler, Theresa // International Student Journal of Nurse Anesthesia;Fall2012, Vol. 11 Issue 3, p27 

    The article presents a case study of a 9 year-old diagnosed with the condition of malignant hyperthermia (MH). Malignant hyperthermia is a hereditary disorder that can be accelerated by volatile anesthetic agents and depolarizing muscle relaxants. Muscle biopsy or genetic testing is the best...

  • Malignant hyperthermia with inhaled anaesthetics in Taiwan.  // Reactions Weekly;11/12/2005, Issue 1077, p4 

    The article reports that inhaled isoflurane and sevoflurane appear to increase the risk of malignant hyperthermia in Taiwanese pediatric patients. The information was based on a study presented at the 5th Annual Meeting of the International Society of Pharmacovigilance in Manila, Philippines in...

  • Isoflurane.  // Reactions Weekly;7/13/2013, Issue 1461, p26 

    An abstract of the article "Continuous veno-venous hemofiltration for massive rhabdomyolysis after malignant hyperthermia: report of 2 cases," by S. Fang and colleagues is presented.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics